You have 9 free searches left this month | to do more
Showing 1 - 25 of
>10,000 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
D
Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal Irradiation
Active, not recruiting
  • Hodgkin's Disease
  • Echo/Stress Echo
  • Boston, Massachusetts
  • +1 more
2022-03-28
Mar 28, 2022
S
Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
Recruiting
  • Lymphoma, Non-Hodgkin
  • Hodgkin's Disease
    • Stanford, California
      Stanford University School of Medicine
    2021-08-02
    Aug 2, 2021
    N
    Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease - 1999
    Completed
    • HIV Infections
    • Hodgkin's Disease
    • Vinblastine sulfate
    • +4 more
    • Birmingham, Alabama
    • +7 more
    2021-10-26
    Oct 26, 2021
    S
    10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma - 2009
    Completed
    Has Results
    • Lymphoma
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    2021-08-20
    Aug 20, 2021
    C
    Feasibility Study of Simvastatin in Hodgkin's Lymphoma Survivors - 2009
    Terminated
    Has Results
    • Carotid Artery Disease
    • New York, New York
      Columbia Univeristy Medical Center
    2021-02-10
    Feb 10, 2021
    B
    Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices - 2020
    Completed
    • Hodgkin's Disease
      • Louisville, Kentucky
        Norton Cancer Institute
      2021-12-14
      Dec 14, 2021
      S
      Maintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in Lymphoma - 2020
      Completed
      Has Results
      • CD20+, B-cell Lymphomas
      • +5 more
      • Baltimore, Maryland
        Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
      2021-10-04
      Oct 4, 2021
      U
      Fitness Assessment in Young Adults Recovered From Lymphoma
      Not yet recruiting
      • Young Adults
      • +2 more
      • Indirect calorimetric test during submaximal exercise
      • Clermont-Ferrand, France
        CHU de Clermont-Ferrand
      2021-12-27
      Dec 27, 2021
      S
      Therapy for Pediatric Hodgkin Lymphoma - 2021
      Completed
      Has Results
      • Hodgkin Lymphoma
      • 12 Week Stanford V Chemotherapy
      • +3 more
      • Palo Alto, California
      • +4 more
      2021-11-23
      Nov 23, 2021
      G
      A Study to Evaluate the Safety, Pharmacokinetics, and Hematopoietic Stem Cell Mobilization of TG-0054 Alone or in Combination With G-CSF in Patients With Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin Disease - 2013
      Completed
      Has Results
      • Multiple Myeloma
      • +2 more
      • Stony Brook, New York
        Stony Brook University Hospital
      2021-04-14
      Apr 14, 2021
      D
      Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies
      Recruiting
      • Non-Hodgkin's Lymphoma
      • +3 more
        • Boston, Massachusetts
          Dana-Farber Cancer Institute
        2021-07-14
        Jul 14, 2021
        B
        Autologous/Allogeneic TGFbeta-resistant LMP-specific CTL, Lymphoma (TGF-beta)
        Active, not recruiting
        • Lymphoma
        • +3 more
        • TGFbeta resistant LMP-specific CTLs
        • Houston, Texas
        • +1 more
        2021-12-08
        Dec 8, 2021
        T
        Drug Use Surveillance for Brentuximab Vedotin Intravenous Infusion "Untreated CD30-Positive Hodgkin's Lymphoma"
        Active, not recruiting
        • Untreated CD30-Positive Hodgkin's Lymphoma
        • Brentuximab vedotin (Genetical Recombination)
        • Tokyo, Japan
          Takeda Selected Site
        2022-03-24
        Mar 24, 2022
        I
        phII Study of an HDAC Inhibitor in Very High-risk Relapsed/Refractory Hodgkin's Lymphoma Patients - 2009
        Terminated
        • Hodgkin's Lymphoma
        • histone deacetylase inhibitor (ITF2357)
        • Milan, Italy
          Istituto Nazionale per lo studio e la cura dei Tumori
        2022-01-18
        Jan 18, 2022
        S
        Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Lymphoma - 2015
        Completed
        • Lymphoma
        • Bleomycin sulfate
        • +7 more
        • Stanford, California
          Stanford Cancer Center at Stanford University Medical Center
        2020-08-10
        Aug 10, 2020
        B
        Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
        Recruiting
        • Hodgkin's Disease
        • +3 more
        • EBV-specific T cells: A
        • EBV-specific T cells: B
        • Houston, Texas
        • +1 more
        2021-11-10
        Nov 10, 2021
        D
        Low-Dose Chest Computed Tomography Screening for Lung Cancer in Survivors of Hodgkin's Disease - 2019
        Completed
        Has Results
        • Lung Cancer
        • chest computed tomography scan
        • Boston, Massachusetts
        • +1 more
        2020-01-09
        Jan 9, 2020
        M
        High-Dose Gemcitabine, Busulfan and Melphalan for Patients With Refactory Hodgkin's Disease - 2018
        Completed
        Has Results
        • Lymphoma
        • Houston, Texas
          University of Texas MD Anderson Cancer Center
        2019-12-13
        Dec 13, 2019
        J
        PD-1 Antibody SHR-1210 in Patients With Relapsed or Refractory Classic Hodgkin's Lymphoma - 2020
        Completed
        • Hodgkin Lymphoma, Adult
        • Beijing, Beijing, China
          Beijing Cancer Hospital
        2021-10-29
        Oct 29, 2021
        W
        The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
        Recruiting
        • Acute Myelogenous Leukemia
        • +9 more
          • Winston-Salem, North Carolina
            Wake Forest Baptist Health
          2021-11-23
          Nov 23, 2021
          N
          Brentuximab Vedotin Plus DHAP in Relapsed or Refractory Hodgkin's Lymphoma
          Recruiting
          • Relapsed/Refractory Classical Hodgkin Lymphoma
          • Brentuximab vedotin
          • Goyang, Gyeonggi-do, Korea, Republic of
            Hyeon-Seok Eom
          2022-02-12
          Feb 12, 2022
          C
          Phase I Vorinostat in Combination With Niacinamide and Etoposide for Lymphoid Malignancies - 2015
          Completed
          Has Results
          • Hodgkin's Disease
          • Non-Hodgkin's Lymphoma
          • New York, New York
            Center for Lymphoid Malignancies at CUMC
          2020-11-05
          Nov 5, 2020
          U
          Administration of T Lymphocytes for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma (CART CD30)
          Active, not recruiting
          • Non-Hodgkin's Lymphoma
          • Hodgkin's Lymphoma
          • CAR.CD30 T cells
          • Chapel Hill, North Carolina
          • +2 more
          2022-03-16
          Mar 16, 2022
          U
          Cardiac Effects in Long-Term Survivors of Hodgkin's and Non-Hodgkin's Lymphoma - 2020
          Completed
          • Hodgkin Disease
          • Lymphoma, Non-Hodgkin
          • Survey
          • Rochester, New York
            University of Rochester Medical Center
          2021-03-04
          Mar 4, 2021
          I
          Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma - 2010
          Completed
          Has Results
          • Hodgkin's Lymphoma
          • Milano, Italy
            Istituto Nazionale per la Cura e lo Studio dei Tumori
          2021-04-20
          Apr 20, 2021